PDCD1 and neoplasm: Although loss of proliferative potential was thought to be a characteristic of exhausted T cells, recent evidence suggests that they may still proliferate in human tumors13,14 and that T cells with an exhausted phenotype expand after anti-PD1 treatment in breast tumors15, but the extent to which these cells retain their anti-tumor functions is unclear16.